LCTX - Lineage Cell Therapeutics looks to raise $14M through direct offering February, 06 2024 09:21 AM BioTime Inc. 2024-02-06 09:21:14 ET More on Lineage Cell Therapeutics Lineage Cell Therapeutics: Not Yet Attractive Stem Cell Company Seeking Alpha’s Quant Rating on Lineage Cell Therapeutics Historical earnings data for Lineage Cell Therapeutics For further details see: Lineage Cell Therapeutics looks to raise $14M through direct offering